Neoleukin Therapeutics
Presença
Neoleukin Therapeutics é uma empresa listada sob o símbolo NLTX (US).
Executivos
Veja o organograma con seus 11 executivos principais
Biografias mais buscadas da Neoleukin Therapeutics
Criar um alerta
para seguir os movimentos de executivos da Neoleukin Therapeutics.
Biotecnologia
Neoleukin Therapeutics possui 2.288 concorrentes concorrentes Lonza (Suíça), Eurofins (Luxemburgo) e Adaptive Phage Therapeutics (Estados Unidos).
Popular M&A news in Biotecnologia
- Attovia Therapeutics acaba de anunciar uma arrecadação de fundos de 150 milhões de dólares. (publicado em 14 de maio de 2024).
- Bruker has announced the acquisition of NanoString Technologies (publicado em 13 de maio de 2024).
- Aardvark Therapeutics acaba de anunciar uma arrecadação de fundos de 85 milhões de dólares. (publicado em 12 de maio de 2024).
Outros contatos sugeridos na indústria do Biotecnologia
Notícias
Últimos comunicados de imprensa de Neoleukin Therapeutics
- Neoleukin Therapeutics to Present at Canaccord Genuity 42nd Annual Growth Conference | Neoleukin Therapeutics, Inc.
- Neoleukin Therapeutics to Host Second Quarter 2022 Financial Results Conference Call and Webcast on August 9, 2022 | Neoleukin Therapeutics, Inc.
- Neoleukin Therapeutics Announces First Patient Treated in Combination Arm of Phase 1 Trial Evaluating NL-201 in Combination with KEYTRUDA® (pembrolizumab) | Neoleukin Therapeutics, Inc.
- Neoleukin Therapeutics Announces First Quarter 2022 Financial Results and Corporate Update | Neoleukin Therapeutics, Inc.
- Neoleukin Therapeutics to Present at Upcoming Investor Conferences | Neoleukin Therapeutics, Inc.
- Neoleukin Therapeutics Announces Preclinical Data for NL-201 at American Association for Cancer Research (AACR) Annual Meeting | Neoleukin Therapeutics, Inc.
- Neoleukin Therapeutics to Present at Canaccord Genuity Horizons in Oncology Conference | Neoleukin Therapeutics, Inc.
- Neoleukin Therapeutics Announces Appointment of Donna Cochener as General Counsel | Neoleukin Therapeutics, Inc.
- Neoleukin Therapeutics Announces Multiple Presentations at American Association for Cancer Research (AACR) Annual Meeting | Neoleukin Therapeutics, Inc.
- Neoleukin Therapeutics Announces Year End 2021 Financial Results and Corporate Update | Neoleukin Therapeutics, Inc.
- View more press releases Close
Redes sociais sobre Neoleukin Therapeutics
- Neoleukin Therapeutics na Wikipedia, Google News e Yahoo Finance
- Neoleukin Therapeutics na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Rohan Palekar 
Ligue para a Neoleukin Therapeutics em +1 206...
